Emergent BioSolutions | Passività Correnti



Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
ALKERMES USD 443.73M 21.47M 2025-03
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 162.41M 17.54M 2025-03
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Exact Sciences USD 502.46M 229.72M 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Glaxosmithkline GBP 21.7B 238M 2024-12
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Ironwood Pharmaceuticals USD 39.15M 10.24M 2024-12
Lonza CHF 3.58B 970M 2024-12
Merck USD 25.17B 3.25B 2025-03
Moderna USD 1.6B 602M 2025-03
Myriad Genetics USD 151.1M 13M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Pacira USD 314.73M 4.81M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
PTC Therapeutics USD 595.39M 14.41M 2025-03
Sanofi 32.22B 3.06B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
United Therapeutics USD 721.5M 16.6M 2025-03



Emergent BioSolutions Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.